Impact of sirolimus on long‐term adverse cardiovascular outcomes in kidney transplant recipients: A nationwide cohort study
These findings suggest that while sirolimus can be a viable option for immunosuppression, it should be used cautiously in those with pre-existing CHF.
Authors
- Wonsuk Choi (ORCID: https://orcid.org/0000-0002-0523-0839)
- Kyung Hee Choi
- Yun Kim (ORCID: https://orcid.org/0000-0002-9809-7351)
- Young‐Mi Ah (ORCID: https://orcid.org/0000-0003-1607-9828)
- Jinhyun Park (ORCID: https://orcid.org/0000-0002-5823-1106)
- Jinseub Hwang (ORCID: https://orcid.org/0000-0002-3805-1546)
- Yun‐Kyoung Song (ORCID: https://orcid.org/0000-0003-3687-4052)
- Ha Young Jang (ORCID: https://orcid.org/0000-0002-4752-1300)
- Jin‐Won Kwon (ORCID: https://orcid.org/0000-0003-3467-7805)
Institutions
- Gachon University (KR)
- Kyungpook National University (KR)
- Daegu Catholic University (KR)
- The Catholic University of Korea Bucheon St. Mary's Hospital (KR)
- Yeungnam University (KR)
- Catholic University of Korea (KR)
- Daegu University (KR)
Publication Details
- Journal
- European Journal of Clinical Investigation
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1111/eci.70027
- Citations
- 1
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.99
Funders
- Ministry of Education